CVSCVS HEALTH Corp

NYSE cvshealth.com


$ 59.01 $ 0.79 (1.36 %)    

Friday, 12-Jul-2024 15:59:52 EDT
QQQ $ 494.79 $ 2.89 (0.59 %)
DIA $ 400.37 $ 2.69 (0.68 %)
SPY $ 559.91 $ 3.51 (0.63 %)
TLT $ 93.88 $ 0.40 (0.43 %)
GLD $ 223.10 $ -0.14 (-0.06 %)
$ 59
$ 58.40
$ 0.00 x 0
$ 0.00 x 0
$ 57.86 - $ 59.56
$ 52.77 - $ 81.71
8,220,232
na
74.75B
$ 0.77
$ 10.21
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 02-07-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-08-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-18-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-14-2018 12-31-2017 10-K
27 11-06-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-02-2017 03-31-2017 10-Q
30 02-09-2017 12-31-2016 10-K
31 11-08-2016 09-30-2016 10-Q
32 08-02-2016 06-30-2016 10-Q
33 05-03-2016 03-31-2016 10-Q
34 02-09-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 08-04-2015 06-30-2015 10-Q
37 05-01-2015 03-31-2015 10-Q
38 02-10-2015 12-31-2014 10-K
39 11-04-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 is-big-pharma-poised-to-take-over-cannabis-3-companies-already-manage-8-in-10-drug-prescriptions-in-the-us

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on d...

Core News & Articles

The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating...

 ftc-investigation-uncovers-anti-competitive-practices-by-handful-of-pharmacy-benefit-managers-including-cvs-health-unitedhealth

The FTC's report reveals how major PBMs like UnitedHealth, CVS, and Cigna influence drug prices, impacting small pharmacies...

 big-pharmacy-benefit-managers-increase-drug-costs-ftc-says---wall-street-journal

https://www.wsj.com/health/healthcare/big-pharmacy-benefit-managers-increase-drug-costs-ftc-says-c6a40ee6?mod=latest_headlines

 bitcoin-dip-not-over-yet-or-the-shorts-are-about-to-get-obliterated-says-ali-martinez

Bitcoin (CRYPTO: BTC) analyst Ali Martinez has recently shared insights on the current state of the cryptocurrency market, sugg...

 cvs-rite-aid-walgreens-hit-hard-by-online-pharmacy-trend

Rite Aid's restructuring plan, approved by a U.S. bankruptcy judge, reduces $2 billion in debt and shifts control to lender...

 walgreens-plans-significant-store-closures-as-it-faces-difficult-operating-environment

Major US pharma chain Walgreens to close undisclosed number of stores due to headwinds, CEO acknowledges challenges. Rite Aid a...

 stock-of-the-day-its-no-coincidence-cvs-health-stock-found-support-where-it-did

It isn't a coincidence that shares of CVS Health Corporation (CVS) found support where they did. It was at a former resista...

 why-is-moderna-stock-trading-lower-on-wednesday

The CDC's Advisory Committee on Immunization Practices is set to discuss recommendations for RSV, influenza, and COVID-19 v...

 investors-worry-how-trump-tariffs-could-further-impact-companies-reliant-on-chinese-suppliers-vulnerable-stocks-have-underperformed-this-year

Donald Trump proposes replacing income taxes with tariffs on foreign goods, causing skepticism from experts and impacting stock...

 judge-rules-against-medimpact-in-200m-rite-aid-debt-dispute

MedImpact's bid to reclaim $200 million after acquiring Rite Aid's pharmacy benefits unit has failed. U.S. Bankruptcy J...

 us-election-and-tariff-prospects-set-to-threaten-internationally-exposed-stocks-goldman-sachs-warns

Election outcome could impact USD & US firms. Betting odds favor Trump & Republican majority, which may strengthen USD ...

 vice-president-kamala-harris-courts-corporate-leaders-amidst-tight-biden-trump-race-report

Kamala Harris actively courts corporate leaders amidst a competitive Biden-Trump race, seeking to bridge gaps and secure busine...